Icon
ICLR • NASDAQ
Icon is a medical - diagnostics & research company in the healthcare sector trading on NASDAQ, led by CEO Barry Balfe, with a market cap of $7.8B.
CEOBarry Balfe
Next Earnings
Upcoming earnings announcement for Icon
Date
Wednesday, April 29, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
$3.04
Revenue Estimate
$2.0B
Earnings History
Past 11 earnings reports for Icon
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Oct 22, 2025 | Q3 2025 | $3.31Est: $3.23 | +2.5% | $2.0BEst: $2.0B | +3.1% | — |
| Jul 23, 2025 | Q2 2025 | $3.26Est: $3.16 | +3.2% | $2.0BEst: $2.0B | +2.0% | — |
| Apr 30, 2025 | Q1 2025 | $3.19Est: $3.08 | +3.6% | $2.0B | — | — |
| Feb 19, 2025 | Q4 2024 | $3.43Est: $3.42 | +0.3% | $2.0BEst: $2.0B | +0.5% | — |
| Oct 23, 2024 | Q3 2024 | $3.35Est: $3.84 | -12.8% | $2.0BEst: $2.1B | -4.7% | — |
| Jul 24, 2024 | Q2 2024 | $3.75Est: $3.68 | +1.9% | $2.1BEst: $2.1B | -0.9% | — |
| Apr 24, 2024 | Q1 2024 | $3.47Est: $3.41 | +1.8% | $2.1BEst: $2.1B | 0.0% | — |
| Feb 21, 2024 | Q4 2023 | $3.46Est: $3.45 | +0.3% | $2.1BEst: $2.1B | -1.2% | — |
| Oct 25, 2023 | Q3 2023 | $3.30Est: $3.28 | +0.6% | $2.1BEst: $2.1B | +0.2% | — |
| Jul 26, 2023 | Q2 2023 | $3.11Est: $3.08 | +1.0% | $2.0BEst: $2.0B | 0.0% | — |
| Apr 26, 2023 | Q1 2023 | $2.90Est: $2.87 | +1.0% | $2.0BEst: $2.0B | -0.1% | — |